Current Report Filing (8-k)
April 30 2019 - 4:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of report (Date of earliest event
reported): April 30, 2019
Acadia Healthcare Company, Inc.
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
|
001-35331
|
45-2492228
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
6100 Tower Circle, Suite 1000
(Address
of Principal Executive Offices)
(615) 861-6000
(Registrant's
Telephone Number, including Area Code)
Not Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions:
⃞
|
Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|
⃞
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
⃞
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
⃞
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of
1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging growth company
⃞
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
⃞
|
Item 2.02 Results of
Operations and Financial Condition.
On April 30, 2019, Acadia Healthcare
Company, Inc. (“Acadia”) issued a press release announcing, among other
things, Acadia’s operating and financial results for the first quarter
ended March 31, 2019. The press release is furnished herewith as
Exhibit 99 hereto and is incorporated herein by reference.
Item 9.01 Financial Statements
and Exhibits.
(d) Exhibits.
99 Press Release of
Acadia Healthcare Company, Inc., dated April 30, 2019.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
ACADIA HEALTHCARE COMPANY, INC.
|
|
|
|
|
|
|
|
|
|
|
|
Date: April 30, 2019
|
|
By:
|
/s/ Christopher L. Howard
|
|
|
|
|
Christopher L. Howard
|
|
|
|
|
Executive Vice President and General Counsel
|
EXHIBIT INDEX
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Apr 2023 to Apr 2024